Arlington, MA, United States of America

Perry F Renshaw

This inventor holds 27 USPTO granted patents and 9 published patent applications and 3 EPO patents, primarily in Psychiatric Treatments. Top assignees: The Mclean Hospital Corporation, University of Utah Research Foundation, Kyowa Hakko Bio Co., Ltd.. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Perry F Renshaw. Retrieved from https://idiyas.com/inventor/perry-f-renshaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 63.0


Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 327(Granted Patents)


Location History:

  • Arlington, MA (US) (1998 - 2011)
  • Bedford, MA (US) (2005 - 2014)
  • Salt Lake City, UT (US) (2010 - 2023)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Cognitive Performance
Citicoline
Magnetic Field Techniques
Psychiatric Disorders
Creatine
Omega-3 Fatty Acid
Bipolar Disorder
Drug Dosage
Mental Conditions
MR Spectroscopy
Substance Abuse
Blue Light
27 patents (USPTO):Explore Patents

Perry Renshaw - The Mastermind behind Latest Innovations in Medical Field

Perry Renshaw, a resident of Bedford Massachusetts, is a prominent inventor and researcher in the field of medical innovations. With numerous patents and inventions under his belt, Perry has been making waves in the industry over the past decade.

His latest inventions involve groundbreaking magnetic field treatment techniques aimed at improving brain function by directly stimulating the neural system. This method is expected to improve the lives of individuals suffering from cognitive disorders such as depression while maintaining safety and comfort.

Perry's work on compounds for treating psychiatric and substance abuse disorders is another small glimpse into his innovative mind. His method of administering a therapeutically effective amount of cytosine-containing, cytidine-containing, creatine-containing, adenosine-containing or adenosine-elevating compounds to a mammal has the potential to revolutionize how these disorders are treated.

Perry Renshaw works for the McLean Hospital Corporation, a renowned hospital that has built a reputation as a center of excellence in all aspects of mental health care. He collaborates with esteemed colleagues such as Michael L. Rohan and Aimee Parow to foster innovation and produce groundbreaking techniques that are helping to reduce suffering and improve the quality of life for millions of people.

Perry's inventive mind is a testament to his grit, determination, and sheer talent in the field of medical innovation. His dedication to his craft is evident in the multiple patents under his name. He is definitely a mastermind in the field of medical research, and his work is sure to change the lives of many for the better.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…